Sotera Health Co (SHC)
Healthcare
Diagnostics & Research
17.90 $
+0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Sotera Health Co (SHC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 67.3% of the shares are freely tradable; institutional investors hold 90.3%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
90.3%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
2.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
67.3%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
285Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Darsana Capital Partners LP | 9.12 | 26,000,000 | +0.0 | 03/31/2026 |
| Sessa Capital, L.P | 8.08 | 23,050,000 | +12.2 | 03/31/2026 |
| OZ Management LLC | 7.62 | 21,717,728 | +3.4 | 03/31/2026 |
| BlackRock Inc | 7.31 | 20,849,579 | +15.3 | 03/31/2026 |
| Vanguard Group Inc | 6.74 | 19,228,375 | +16.7 | 12/31/2025 |
| Warburg Pincus LLC | 6.70 | 19,102,952 | -44.0 | 03/31/2026 |
| GTCR LLC | 4.47 | 12,735,301 | -44.0 | 03/31/2026 |
| Sachem Head Capital Management LP | 4.08 | 11,645,000 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.76 | 10,735,006 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.72 | 10,608,717 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.